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Abstract: With an annual incidence greater than 65,000 in the United 
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affecting those over 65. Treatment is based on the anatomical location of 
the fracture relative to the capsule of the hip joint - fractures 
occurring within it are treated by arthroplasty, while extracapsular 
fractures are an indication for fixation. Intertrochanteric fractures are 
further grouped as stable (AO/OTA 31A1/A2) or unstable (31A3) which in 
turn governs in the current UK guidelines whether this fixation is 
achieved with a dynamic hip screw or intramedullary device. Anecdotally, 
some units are tending towards intramedullary devices for 31A2 fractures 
as well, a practice which from the evidence does not appear to confer 
benefit and carries an excess cost. We reviewed our data submitted to the 
National Hip Fracture Database over the last five years and identified 
all intertrochanteric fractures, from which cohort we identified all 
patients with 31A2 fractures by review of radiographs. The cohort 
comprised 370 patients. We then recorded age, gender, ASA grade, 
abbreviated mental test score, residence from where admitted, length of 
stay, destination on discharge and whether any further operations were 
required. There was no significant difference in the demographics of the 
groups, year-on-year, except gender mix. There was a significant, twenty-
fold rise in the use of intramedullary devices between 2011 and 2015. 
Length of stay, length of overall episode of care, revision rates, 
mortality and destination on discharge were unchanged. This use is not 
supported by NICE guidelines and this study offers no evidence to 
contradict this position. We advocate all centres examine their practice 
to avoid a costly intervention without clinical benefit. 
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 Abstract 
 
With an annual incidence greater than 65,000 in the United Kingdom, hip fractures 
are a common but debilitating injury predominantly affecting those over 65. 
Treatment is based on the anatomical location of the fracture relative to the capsule of 
the hip joint - fractures occurring within it are treated by arthroplasty, while 
extracapsular fractures are an indication for fixation. Intertrochanteric fractures are 
further grouped as stable (AO/OTA 31A1/A2) or unstable (31A3) which in turn 
governs in the current UK guidelines whether this fixation is achieved with a dynamic 
hip screw or intramedullary device. Anecdotally, some units are tending towards 
intramedullary devices for 31A2 fractures as well, a practice which from the evidence 
does not appear to confer benefit and carries an excess cost. We reviewed our data 
submitted to the National Hip Fracture Database over the last five years and identified 
all intertrochanteric fractures, from which cohort we identified all patients with 31A2 
fractures by review of radiographs. The cohort comprised 370 patients. We then 
recorded age, gender, ASA grade, abbreviated mental test score, residence from 
where admitted, length of stay, destination on discharge and whether any further 
operations were required. There was no significant difference in the demographics of 
the groups, year-on-year, except gender mix. There was a significant, twenty-fold rise 
in the use of intramedullary devices between 2011 and 2015. Length of stay, length of 
overall episode of care, revision rates, mortality and destination on discharge were 
unchanged. This use is not supported by NICE guidelines and this study offers no 
evidence to contradict this position. We advocate all centres examine their practice to 
avoid a costly intervention without clinical benefit.  
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Introduction 
 
Hip fractures had an annual incidence in excess of 65,000 in 2015 (Royal College of 
Physicians 2015), cost over £1bn in hospital care alone (Leal et al. 2015) and 
represent a significant life-altering event for the patient. It has recently been 
demonstrated that these patients lose a significant quality of life permanently and, 
early in their recovery, a proportion rate their state of health as worse than being dead 
(Griffin, Parsons, Achten, Fernandez & Costa 2015b). While care has advanced 
substantially in recent years, there remains a significant burden of mortality 
associated with the injury (Holt et al. 2008). 
 
Recognising the severity of the problem, the National Institute for Health and Care 
Excellence published Clinical Guideline 124 (CG124) in 2011, setting out a number 
of quality indicators for the care of these patients. These focused on pre-operative 
medical optimization, timely, consultant-led surgery and peri-operative care to avoid 
the common complications and co-morbidities. 
 
The approach to the management of extracapsular (AO/OTA classification 31Ax) hip 
fractures is based on fixation, preserving the native femoral head by use of dynamic 
hip screw (DHS) or intramedullary devices to stabilize the fracture and allow the neck 
to collapse into a position of compression. While there exists some debate between 
surgeons over which defers confers biomechanically superior fixation, CG124 
advocates DHS fixation for undisplaced, simple fractures (31A1) and 31A2 (multi-
fragmentary fractures as distal as the lesser trochanter). Intramedullary fixation is 
limited to 31A3 (fractures with sub-trochanteric extension or inherently unstable, 
reverse-oblique fractures)[4–6]. 
 
The choice of implant is important as inadequate fixation will lead to cut-out of the 
device from the femoral head (Baumgaertner 1997), mandating revision surgery. Such 
surgery places the patient at greater risk and vastly increases the costs of the hip 
fracture to the NHS (Broderick et al. 2013). 
 
The current evidence base suggests most 31A2 proximal femoral fractures can be 
managed with a DHS {Reindl:2015bw}. A recent cost-modelling analysis 
demonstrated increased cost-effectiveness of the DHS with a failure rate of up to 5%, 
after which nailing became the economically preferable option (Swart et al. 2014). 
Anecdotally, there has nonetheless been a shift in some units from DHS to 
intramedullary fixation for 31A2 fractures.  
 
The aim of this study was to quantify the annual comparative volume of DHS and 
intramedullary fixation procedures and identify any differences in outcome. 
 
  
Patients and methods 
 
Our centre’s submission dataset for the National Hip Fracture Database was queried 
to identify all those patients who had sustained intertrochanteric fractures between 
January 2011 and June 2015. The radiographs were all reviewed by one of three 
authors to exclude patients with 31A1 or A3 fractures. Other exclusion criteria were 
age below 65 years and pathological fracture (Figure 1). Ethical approval was not 
required for this evaluation of our service. 
 
The data collected on each patient was: age; gender; American Society of 
Anesthesiologists (ASA) grade; Abbreviated Mental Test Score (AMTS); place of 
residence; surgery performed; dates of admission, surgery and discharge from acute 
ward, NHS trust and NHS care; discharge destination and date and nature of any 
further operations pertaining to this episode of care. 
 
The patients were grouped by operation – DHS or intramedullary fixation (IMN). 
Places of residence on admission were coded as 1 (nursing, acute or rehabilitation 
care), 2 (residential care) or 3 (own home or sheltered housing) and discharge 
destinations were coded as 0 (did not survive to discharge), 1 2 or 3 as above. These 
codes were used as surrogates for levels of independence of function, the key 
objective of hip fracture surgery being the restoration of such function. 
 
Our primary outcome measure was the number of DHS and IMN procedures 
performed each year. The secondary outcome measures were length of ward stay, 
length of the total episode of care, change in level of independence and requirement 
for further surgery.   
 
Data were tested for normality by the Shapiro Wilk method. All comparisons were 
made by Chi squared testing for categorical and Mann Whitney U or Kruskal Wallis 
testing for continuous or ordinal data. Statistical analysis was performed using SPSS 
version 21 (IBM, New York, USA). 
 
The available dataset for the relevant time period comprised in total 1086 patients. 
The number of patients meeting the inclusion criteria was 370 (Figure 1). 
  
Results 
 
Demographic information on the groups is given in Tables 1 and 2. The mean age was 
85.99 (95% CI 85.27-86.71) years and 255 (68.9%) patients were female. The gender 
distribution of patients was significantly different by year and by implant group 
(p<.001). No significant differences existed in terms of age, co-morbidity, cognitive 
function or pre-injury level of independence of living when grouping patients by 
either year of surgery or implant used. 
 
There was a significant (p<.001), year-on-year increase in the use of intramedullary 
nails (Figure 3). 
 
There was no significant difference in the length of ward stay or duration of the care 
episode, although there were a large number of missing data points for the duration of 
care (Table 3). Both mortality and the distribution of level of independence of living 
on discharge was also similar between groups (p=.192)
Discussion 
 
This is the first study to quantify temporal changes in the use of differing implants for 
AO/OTA 31A2 hip fractures in the UK and one of few to include a relatively large 
cohort with the newest generation of intramedullary devices. We have demonstrated a 
statistically significant year-on-year increase in utilisation of intramedullary devices 
without any change in length of stay, level of independence on discharge or 
requirement for further surgery. The trend in utilisation of nails from 3.8% of A2 
fractures in 2011 to in excess of 57.6% at time of analysis in 2015 is not one driven 
by any change in patient characteristics within this time period. While this study was 
not able to ascertain the reason for implant selection, in a demographically 
unchanging cohort there is little suggestion that the proportion of unexpectedly 
unstable fractures should differ from year to year. 
 
The excess implant cost to our centre when opting for intramedullary fixation is 
£884.01 (£1164.43 for the Synthes PFNA with compression screw and two distal 
locking screws versus £280.42 for the DHS with a four-hole plate and four cortical 
screws). Should trends in both usage and cost differentials be generalizable to any 
extent in a national context, the excess costs to the NHS could be in the order of 
millions of pounds. 
 
The increased cost of IMNs has often been justified by claims of lower rates of 
complication, shorter length of stay or higher level of functional independence on 
discharge and hence reduced societal care costs for these patients. In this study, we 
have not demonstrated this to be the case and there has been a consistent absence 
from the literature of unequivocal evidence of superiority of intramedullary fixation. 
Aros et al’s 2008 Medicare-based study of more than 43,000 intertrochanteric 
fractures demonstrated increased revision rates in the intramedullary fixation group 
and, when appropriately adjusting the data, increased length of stay, rehabilitation 
requirements and overall costs (Aros et al. 2008). Mortality was similar in both 
groups. 
 
Giraud et al demonstrated equivocal outcomes of DHS and Targon intramedullary 
devices with less blood loss and shorter operative times in their 60 patient randomized 
trial (Giraud et al. 2005). Klinger et al found shorter operative time, length of stay and 
time to remobilization with the PFN over the DHS but this was in a cohort including 
patients with 31A2 and 31A3 fractures (Klinger et al. 2005). Liu et al’s 2009 meta-
analysis found no benefit in the Gamma nail over the DHS in seven studies, although 
there was a degree of heterogeneity in the studies included (Liu et al. 2009). While the 
PFNA and Gamma nail differ in design, the core concepts that some cite as conferring 
benefit, such as the shorter lever arm, are common across all such devices. Such 
theoretical benefits have not been proven in the literature to translate to a clinical 
advantage in A2 fractures. Any such potential benefit must also be balanced with nail-
specific problems such as cortical perforation when the radius of curvature of bone 
and implant are mismatched. 
 
Within the last year, a large randomized controlled trial of DHS versus IMN 
demonstrated that while IMNs conferred less femoral neck shortening, this did not 
translate to improved lower extremity measurement, functional independence 
measurement or timed up-and-go scores (Reindl et al. 2015). No differences were 
seen in morbidity or mortality. 
 
This study could be criticised for being observational . The similarity between cohorts 
in terms of age, gender, ASA grade and level of independent living pre-injury 
suggests, however, that the cohorts are broadly comparable. The gender of a number 
of patients was not readily accessible for the dataset and the largest variation in 
distribution of gender between subgroups in the cohort actually pertains to missing 
data; were all these available the significant differences may no longer exist. The 
single-surgeon classification of the fracture is also more prone to error than blinded 
double- or triple-classification. The proportion of fractures classified as 31A2 in 2013 
is also not readily explicable from the data, but while the absolute number appears an 
outlier, the relative mix of operations that year was on-trend. 
 
The single-centre nature of this study risks it being unrepresentative of wider practice 
but there has been anecdotal suggestion that trauma centres using more intramedullary 
fixation in routine practice for other fractures tend towards this when managing hip 
fractures; a multi-centre study would confirm or refute this theory. The number of 
surgeons operating in our centre over the five year study period also renders surgeon-
dependent error unlikely and hence the implant-associated trends seen here are likely 
to be generalizable. 
 
Discharge destination as an outcome measure may lack the depth of information of a 
scoring system but convincing arguments have been made that an adequate system 
specifically designed for hip fractures does not yet exist. While overall health 
indicators such as the EQ-5D have been accepted as reasonable compromises in that 
they can capture an adequate amount of information on these sometimes parlous 
health states and have adequate validity when completed by relatives or carers 
(Parsons et al. 2014), the ultimate question in hip fracture care is whether we are 
restoring pre-injury function to these patients. This has been qualitatively 
demonstrated to be patients’ greatest concern when considering hip fracture (Griffiths 
et al. 2015) and clear effects have been shown in recent output from the Warwick Hip 
Trauma Evaluation (WHiTE) study (Griffin, Parsons, Achten, Fernandez & Costa 
2015a; Griffin et al. 2012). 
 
As this data is sourced locally rather than from national datasets, there is a possibility 
that patients who have experienced complications from their surgery have presented 
elsewhere and this episode has not been captured. There is no reason to believe this to 
be either a significant trend or one seen disproportionately in one group and the 
complication rate seen in the DHS group is also very similar to other UK-based 
analyses (Chirodian et al. 2005). 
 
The findings of this study demonstrate a year on year increase in the use of 
intramedullary fixation for AO/OTA 31A2 hip fractures; these do not confer any 
benefits in terms of outcome and lead to higher treatment costs. 
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 Variable 
Year group 
 
 
p 
 2011 2012 2013 2014 2015 
Number of patients 
n 
52 85 131 69 33  
Gender 
n (%) 
Male 18 (34.6) 20 (23.5) 34 (26.0) 12 (17.4) 9 (27.3) <.001 
Female 34 (65.4) 63 (74.1) 96 (73.3) 53 (76.8) 9 (27.3) 
Mean age 
Yrs (95% CI) 
85.22 
(82.79-
87.64) 
85.94 
(84.48-
87.39) 
86.26 
(85.12-
87.40) 
86.84 
(85.35-
88.33) 
83.91 
(81.30-
86.53) 
.311 
ASA grade 
n (%) 
1 0 (0) 1 (1.2) 3 (2.3) 2 (2.9) 1 (3.0) .952 
2 11 (22.4) 20 (24.1) 39 (29.8) 19 (27.5) 11 (33.9) 
3 31 (63.3) 52 (62.7) 73 (55.7) 39 (56.5) 19 (57.6) 
4 7 (14.3) 10 (12.0) 16 (12.2) 9 (13.0) 2 (6.1) 
Mean AMTS (95% CI) 6.67 (5.57-
7.78) 
6.87 (6.08-
7.66) 
6.68 (6.08-
7.27) 
7.14 
(6.29-
8.00) 
7.48 
(6.32-
8.65) 
.746 
Admitted from 
n (%) 
Own home or sheltered accommodation 36 (70.6) 60 (71.4) 104 (80) 57 (82.6) 29 (87.9) .183 
Residential care 8 (15.7) 12 (14.3) 17 (13.1) 10 (14.5) 3 (9.1) 
Nursing, rehabilitation or hospital care 7 (13.7) 12 (14.3) 9 (6.9) 2 (2.9) 1 (3.0) 
 
Table 1 – Patient demographics grouped by year 
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Table 2 – Patient demographics by implant 
 
 
 
Variable 
Implant 
 
 
P 
 DHS IMN 
Number of patients 
n 
267 103  
Gender 
n (%) 
Male 74 (27.7) 19 (18.4) <.001 
Female 187 (70.0) 68 (66.0) 
Mean age 
yrs (95% CI) 
85.90 
(85.05-
86.76) 
86.03 
(84.72-
87.33) 
.881 
ASA grade 
n (%) 
1 4 (1.5) 3 (2.9) .836 
2 73 (27.9) 27 (26.2) 
3 154 (58.8) 60 (58.3) 
4 31 (11.8) 13 (12.6) 
Mean AMTS (95% CI) 6.98 (6.55-
7.41) 
6.63 (5.92-
7.33) 
.392 
Admitted from 
n (%) 
Own home or sheltered accommodation 208 (78.8) 78 (75.7) .348 
Residential care 32 (12.1) 18 (17.5) 
Nursing, rehabilitation or hospital care 24 (9.1) 7 (6.8) 
Table2
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Variable Implant p 
DHS IMN 
Additional 
procedures 
required 
n (%) 
Washout 3 (1.12) 2 (1.94) .231 
Revision of / to IMN 1 (0.37) 2 (1.94) 
Arthroplasty 3 (1.12) 0 (0.0) 
Mean length of ward stay days (95% CI) 5.92 (4.91-
6.93) 
6.31 
(4.95-
7.68) 
.677 
Mean length of episode of care days (95% CI) 18.71 (12.50-
24.91) 
31.03 
(21.22-
40.85) 
.076 
 
Discharged to 
n (%) 
Own home or sheltered 
accommodation 
37 (28.5) 4 (14.3) .192 
Residential care 21 (16.2) 3 (10.7) 
Nursing, rehabilitation or 
hospital care 
61 (46.9) 16 (57.1) 
Did not survive to discharge 11 (8.5) 5 (17.9) 
 
Table 3 – Outcomes by implant  
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